Gene-Based Tests for Screening, Detection, and/or Management of Prostate Cancer "Notification"
Evidence Based Guideline converted to Corporate Medical Policy. "Description"section updated. "Policy"statement added indicating "Genetic tests for the screening, detection, and management of prostate cancer are considered investigational for all applications. BCBSNC does not provide coverage for investigational services or procedures." Specialty Matched Consultant Advisory Panel review 8/31/2011. References added. Notification given 9/30/2011 Policy effective 1/1/2012.